Thrombopoietin receptor — Drug Target

All drugs that target Thrombopoietin receptor — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Thrombopoietin Receptor Agonist [EPC] · Thrombopoietin Receptor Agonist · Thrombopoietin receptor agonist

Marketed (5)

• Nplate · Amgen · Thrombopoietin Receptor Agonist [EPC] · Cardiovascular
  Nplate works by binding to the thrombopoietin receptor to stimulate platelet production.
• Promacta · Novartis · Thrombopoietin Receptor Agonist · Oncology
  Promacta works by binding to the thrombopoietin receptor, stimulating platelet production in the bone marrow.
• Mulpleta · Vancocin Italia · Cardiovascular
  Mulpleta works by binding to the thrombopoietin receptor, stimulating platelet production in the bone marrow.
• Nplate · Nantes University Hospital · Cardiovascular
• Doptelet · Akarx Inc · Cardiovascular
  Doptelet works by binding to the thrombopoietin receptor, stimulating platelet production in the bone marrow.

Phase 3 pipeline (2)

• Thrombopoietin Receptor Agonist · The First Affiliated Hospital of Soochow University · Thrombopoietin Receptor Agonist · Hematology
  Thrombopoietin Receptor Agonists stimulate the thrombopoietin receptor to increase platelet production.
• Romiplostim N01 · Qilu Pharmaceutical Co., Ltd. · Thrombopoietin receptor agonist · Hematology
  Romiplostim N01 is a thrombopoietin receptor agonist that stimulates platelet production.

Phase 2 pipeline (2)

• Avatrombopag tablets · Eisai Inc. · Thrombopoietin receptor agonist · Oncology
  Thrombopoietin receptor agonist
• AMG531 · Kyowa Kirin Korea Co., Ltd. · Thrombopoietin receptor agonist · Hematology
  AMG531 is a thrombopoietin receptor agonist.